arginyl-glycyl-aspartic acid and Leukemia, Lymphocytic, T Cell

arginyl-glycyl-aspartic acid has been researched along with Leukemia, Lymphocytic, T Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, CJ; Deng, H; Sprague, JE; Wadas, TJ; Weilbaecher, KN; Zheleznyak, A	1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartic acid and Leukemia, Lymphocytic, T Cell

Article	Year
Targeting the alphavbeta3 integrin for small-animal PET/CT of osteolytic bone metastases. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50, Issue:11 Topics: Animals; Bone Neoplasms; Copper Radioisotopes; Diagnosis, Differential; Diphosphonates; Gene Expression Regulation, Neoplastic; Gene Products, tax; Humans; Leukemia, T-Cell; Mice; Multiple Myeloma; Oligopeptides; Osteoclasts; Osteolysis; Positron-Emission Tomography; Receptors, Vitronectin; Spine; Tail; Tomography, X-Ray Computed; Treatment Outcome	2009

Article

Year

Targeting the alphavbeta3 integrin for small-animal PET/CT of osteolytic bone metastases.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50, Issue:11

Topics: Animals; Bone Neoplasms; Copper Radioisotopes; Diagnosis, Differential; Diphosphonates; Gene Expression Regulation, Neoplastic; Gene Products, tax; Humans; Leukemia, T-Cell; Mice; Multiple Myeloma; Oligopeptides; Osteoclasts; Osteolysis; Positron-Emission Tomography; Receptors, Vitronectin; Spine; Tail; Tomography, X-Ray Computed; Treatment Outcome

2009